Valley National Advisers Inc. reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 98.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78 shares of the company’s stock after selling 4,610 shares during the period. Valley National Advisers Inc.’s holdings in HCA Healthcare were worth $33,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Signaturefd LLC lifted its stake in HCA Healthcare by 2.3% during the third quarter. Signaturefd LLC now owns 17,030 shares of the company’s stock worth $7,267,000 after purchasing an additional 387 shares during the last quarter. Simplicity Wealth LLC boosted its stake in HCA Healthcare by 42.4% during the 3rd quarter. Simplicity Wealth LLC now owns 2,553 shares of the company’s stock valued at $1,090,000 after purchasing an additional 760 shares during the period. Evergreen Capital Management LLC grew its holdings in HCA Healthcare by 25.5% in the 3rd quarter. Evergreen Capital Management LLC now owns 1,661 shares of the company’s stock worth $709,000 after buying an additional 338 shares in the last quarter. Wedbush Securities Inc. acquired a new stake in HCA Healthcare in the 3rd quarter valued at approximately $207,000. Finally, Fifth Third Wealth Advisors LLC raised its stake in HCA Healthcare by 9.9% during the 3rd quarter. Fifth Third Wealth Advisors LLC now owns 2,691 shares of the company’s stock valued at $1,148,000 after acquiring an additional 243 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.
HCA Healthcare Stock Down 1.0%
Shares of HCA Healthcare stock opened at $464.45 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a market cap of $100.55 billion, a PE ratio of 15.55, a price-to-earnings-growth ratio of 1.58 and a beta of 1.10. The business has a fifty day simple moving average of $431.57 and a 200-day simple moving average of $445.15.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same period in the previous year, the firm earned $6.84 earnings per share. HCA Healthcare’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts expect that HCA Healthcare, Inc. will post 29.51 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research analysts have issued reports on the company. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Barclays lowered their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday, July 27th. Oppenheimer cut their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a research note on Monday, July 27th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research report on Tuesday, July 14th. Finally, Raymond James Financial set a $528.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 7th. Sixteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $467.50.
Read Our Latest Research Report on HCA
HCA Healthcare Company Profile
HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.
The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.
Further Reading
- Five stocks we like better than HCA Healthcare
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
